These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Native T1 heterogeneity for predicting reverse remodeling in patients with non-ischemic dilated cardiomyopathy. Kinoshita M; Kato S; Kodama S; Azuma M; Nakayama N; Fukui K; Saito N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D Heart Vessels; 2022 Sep; 37(9):1541-1550. PubMed ID: 35320392 [TBL] [Abstract][Full Text] [Related]
6. T1 Map-Based Radiomics for Prediction of Left Ventricular Reverse Remodeling in Patients With Nonischemic Dilated Cardiomyopathy. Chang S; Han K; Kwon Y; Kim L; Hwang S; Kim H; Choi BW Korean J Radiol; 2023 May; 24(5):395-405. PubMed ID: 37133210 [TBL] [Abstract][Full Text] [Related]
7. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Left Ventricular Longitudinal Function and Myocardial Fibrosis in Patients With Ischemic and Non-Ischemic Dilated Cardiomyopathy Concomitant With Type 2 Diabetes Mellitus: A 3.0 T Cardiac MR Study. Zhang HK; Du Y; Shi CY; Zhang N; Gao HQ; Zhong YL; Wang MZ; Zhou Z; Gao XL; Li S; Yang L; Liu T; Fan ZM; Sun ZH; Xu L J Magn Reson Imaging; 2024 Jan; 59(1):164-176. PubMed ID: 37013673 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of discrepant mid-wall late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy. Ehara S; Matsumoto K; Kitada R; Nishimura S; Shimada K; Yoshiyama M Heart Vessels; 2018 Dec; 33(12):1482-1489. PubMed ID: 29804280 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients. Behera DR; V K AK; K K NN; S S; Nair KKM; G S; T R K; Gopalakrishnan A; S H Indian Heart J; 2020; 72(5):362-368. PubMed ID: 33189195 [TBL] [Abstract][Full Text] [Related]
13. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992 [TBL] [Abstract][Full Text] [Related]
14. Long term prognostic importance of late gadolinium enhancement in first-presentation non-ischaemic dilated cardiomyopathy. Sree Raman K; Nucifora G; Leong DP; Marx C; Shah R; Woodman RJ; Molaee P; Shirazi MG; McGavigan AD; De Pasquale CG; Selvanayagam JB Int J Cardiol; 2019 Apr; 280():124-129. PubMed ID: 30679073 [TBL] [Abstract][Full Text] [Related]
15. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes. Chun KH; Oh J; Hong YJ; Yu HT; Lee CJ; Kim TH; Joung B; Pak HN; Lee MH; Kim YJ; Kang SM J Am Heart Assoc; 2022 Mar; 11(6):e023167. PubMed ID: 35261277 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy. Ishii S; Inomata T; Fujita T; Iida Y; Ikeda Y; Nabeta T; Yanagisawa T; Naruke T; Mizutani T; Koitabashi T; Takeuchi I; Ako J Heart Vessels; 2016 Dec; 31(12):1960-1968. PubMed ID: 26920939 [TBL] [Abstract][Full Text] [Related]
18. Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study. Nabeta T; Inomata T; Fujita T; Iida Y; Ikeda Y; Sato T; Ishii S; Maekawa E; Mizutani T; Naruke T; Koitabashi T; Inoue Y; Ako J J Cardiol; 2017 Aug; 70(2):185-191. PubMed ID: 27979675 [TBL] [Abstract][Full Text] [Related]
19. Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy. Nabeta T; Inomata T; Iida Y; Ikeda Y; Iwamoto M; Ishii S; Sato T; Watanabe I; Naruke T; Shinagawa H; Koitabashi T; Takeuchi I; Nishii M; Inoue Y; Izumi T Heart Vessels; 2014 Nov; 29(6):784-92. PubMed ID: 24092362 [TBL] [Abstract][Full Text] [Related]
20. Identification of patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias: insights from cardiac magnetic resonance feature tracking. Ma HY; Xie GY; Tao J; Li ZZ; Liu P; Zheng XJ; Wang RP BMC Cardiovasc Disord; 2024 Jan; 24(1):29. PubMed ID: 38172720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]